Rare case of intraintestinal stromal tumors in the patient with familial adenomatous polyposis by Lozynska, M.R. et al.
Experimental Oncology 37, 227–230, 2015 (September) 227
RARE CASE OF INTRAINTESTINAL STROMAL TUMORS 
IN THE PATIENT WITH FAMILIAL ADENOMATOUS POLYPOSIS
M.R. Lozynska1,*, Y.O. Pospishil2, O.Y. Varyvoda2, A. Pławski3, O.O. Pretsel4
1SI “Institute of Hereditary Pathology of the NAMS of Ukraine”, Lviv 79000, Ukraine
2Danylo Halytsky Lviv National Medical University, Lviv 79010, Ukraine
3Institute of Human Genetics of PAS, Poznan 60–479, Poland
4Lviv Regional Clinical Hospital, Lviv 79010, Ukraine
Aim: To describe the case of metachronous gastrointestinal stromal tumors in a proband with familial adenomatous polyposis (FAP), 
carrier of APC gene mutation in codon 1309. Material and Methods: The physical examination, genealogical analysis and molecu-
lar genetic analysis of peripheral blood in 15-years-old girl with FAP and her sister, were carried out. Macroscopic, standard 
histological and immunohistochemical study of surgical specimens — intraintestinal tumors of the small intestine in proband was 
performed. Results: Extraintestinal manifestations, including congenital abnormalities of facial skeleton, typical for Gardner’s syn-
drome, were observed in the sisters with FAP as the addition symptoms of the disease. Frameshift mutation in codon 1309 in the APC 
gene was detected in these patients. A rare neoplasia — metachronous gastrointestinal stromal tumor was found in proband 15 months 
after total colectomy for FAP. This is the third case described in the accessible medical literature. Conclusion: The possible role 
of APC gene mutation in the development of mesenchymal neoplasms is discussed. The study of stromal tumors is important for 
understanding of their pathogenesis that will enable to develop effective targeted therapy.
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In 1951 Gardner described a rare clinical case 
of familial adenomatous polyposis (FAP) with auto-
somal dominant pattern of inheritance with almost 
complete penetrance associated with extracolonical 
manifestations (ECM). FAP represents less than 1% 
of all colorectal cancer cases, and is the most common 
gastrointestinal polyposis syndrome with an incidence 
of 1:10000–15000 subjects [1, 2]. APC mutations were 
found in 80% (95% CI 71–87%) of individuals with more 
than 1000 adenomas, 56% (95% CI 54–59%) in those 
with 100–999 adenomas, 10% (95% CI 9–11%) in those 
with 20–99 adenomas, and 5% (95% CI 4–7%) in those 
with 10–19 adenomas [3]. The human APC gene (OMIM 
611731) is located on the long (q) arm of chromosome 
5 in band q22.2. Since the identification of the APC 
gene, more than 1100 unique likely pathogenic germline 
mutations have been reported (http://www.lovd.nl/apc). 
The APC gene encodes a protein of 2,843 aminoacids 
(310 kDa) that plays an outright role in the Wnt signal-
ing pathway [4]. The APC protein functions as a tumor 
suppressor by negatively regula ting the β-catenin 
oncoprotein. The APC protein leads to ubiquitination 
and degradation of β-catenin; so in the absence of it, 
β-catenin accumulates in the nucleus and interacts 
with factors that up-regulate the transcription of genes 
involved in cell cycle entry, proliferation, differentiation, 
migration, apoptosis, and progression [5]. Approxi-
mately 15–20% are considered as “de novo” cases 
without any family history of the disease [6]. In pa-
tients with FAP first symptoms are often manifested 
in puberty. These include dyspepsia with frequent 
liquid defecation, abdominal pain, anaemia, metabolic 
disorders leading to a delay in physical development. 
More than 80% of patients had low level of total protein, 
albumin, cholesterol, decreased immunity when the 
disease to progresses [7]. These symptoms increase 
with the advance of the disease, leading to infantilism, 
exhaustion that caused to the development of ca-
chexia. The earlier FAP is manifested, the severer is its 
course, and the sooner decompensation state follows. 
The average age of the disease manifestation is about 
26–33 years [8–10]. FAP often combined with different 
malignant tumors such as: colon cancer, duodenal and 
periampullary cancer [11], hepatoblastoma, gastric 
cancer, thyroid cancer [12], pancreatic and breast can-
cer [13] that is in 10 or 100 times greater than general 
population level.
Gardner’s syndrome is characterized by the fol lowing 
ECM used for screening of the disease: congenital mal-
formations of the facial skeleton [8, 14], tumors of soft 
tissues (desmoid tumors, fibromas, lipomas, epidermal 
cysts, nasopharyngial angiofibromas), congenital hyper-
trophy of the retinal pigment epithelium [1, 15]. Desmoid 
intra-abdominal tumors are detected in 80% of patients 
with FAP [16]. In more than half of the patients epidermal 
cysts that can occur on the extremities, face, and head, 
much earlier than polyps, causing a cosmetic defect, are 
diagnosed. Multiple osteomas of the mandible, extremi-
ties and bone tumors are also frequent. All of these pro-
cesses affirm the changes of mesenchymal tissue [15].
Gastrointestinal stromal tumors (GIST) are the 
most common primary mesenchymal neoplasms 
of the gastrointestinal system. GIST can occur 
anywhere along the gastrointestinal tract, but most 
often are found in the stomach (66%) and only 25% 
of cases — in the small intestine [17]. They may 
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originate from interstitial cells of Cajal or their stem 
cell-like precursors, although this is not certain [18]. 
The estimated annual incidence reported in popula-
tion-based studies is between 11 and 15 per million 
people [19, 20]. The incidence peak and the median 
age at diagnosis are of about 60–65 years. However, 
the distribution by age is wide, and GIST can occur 
during childhood or at 90 years of age. GIST are spo-
radic in their great majority but, in rare cases, found 
in patients with genetic predisposition [17, 21], rarely 
combined with other kinds of neoplasia, or it may oc-
cur as a part of multitumoral disease combined with 
neurofibromatosis 1, Carney triad and multiple en-
docrine neoplasia — MEN syndrome [22]. GIST are 
independent clinical entities having individual histo-
logical, immunohistochemical and molecular genetic 
features. Verification of diagnosis of stromal tumor 
means identification of the expression of KIT (CD117) 
by immunohistochemical method. Approximately 95% 
of GIST are positive for the CD117 antigen, a marker 
expressed by interstitial cells of Cajal, an epitope 
of the KIT receptor tyrosine kinase, and 80% of these 
tumors are positive for CD34 antigen [23]. More than 
90% of GIST are malignant. GIST are occurred rarely 
in patients with FAP. It was described only two cases 
in the accessible medical literature [24, 25].
The aim of this study is to describe the case of meta-
chronous GIST in a proband with Gardner’s syndrome, 
carrier of APC gene mutation in codon 1309.
MATERIALS AND METHODS
The physical and endoscopic examinations 
of 15-year-old girl and her relatives — father and 
sister, were carried out. The genealogical analysis 
in three generations of patient’s family was performed 
for determining the type of inheritance. Patients were 
the residents of Lviv region.
Molecular genetic study of peripheral blood 
of proband and her sister aged 13 years was carried out. 
Before blood sampling for molecular genetic studies 
informed consent to perform such analysis from pa-
tient’s mother was obtained. Genomic DNA was isolated 
from peripheral blood using salting-out method [26]. 
Primers were used including individual exonic splicing 
sites. The amplified fragments of the APC gene were 
screened for mutations involving the heteroduplex 
analysis (HD) and detection of single-stranded confor-
mational polymorphism (SSCP) [27]. The heteroduplex 
DNA fragments detected in the HD analysis or various 
patterns in the SSCP analysis were further analysed 
by direct PCR product sequencing, using MEGABace 
500 sequencer (General Electric Health Care, USA) 
according to the manufacturer’s specifications [28].
Macroscopic, standard histological and immu-
nohistochemical study of surgical specimens — in-
traintestinal tumors of the small intestine in proband 
was carried out. Gross specimens were stained 
by standard hematoxylin and eosin. Immunohisto-
chemical studies of tumors of mesenchymal genesis 
using monoclonal antibodies to vimentin, desmin, 
CD117, CD34, produced by Dako (Denmark) for the 
differential diagnosis were carried out. Microphotos 
of GIST samples were performed using photosystem 
“Leica” DFC420 camera and Leica Dm 750/4 micro-
scope (Germany).
RESULTS AND DISCUSSION
We report a case of a 15-year-old girl with 
FAP. Colonoscopy revealed multiple adenomas 
(> 100) in all parts of the colon in this patient. Her 
sister had polyps in colon and her father had polyps 
in colon and in sto mach. Gardner’s syndrome was 
diagnosed in proband at the age of 15 years. The di-
agnosis was confirmed using molecular genetic 
studies of blood samples. Screening of the APC gene 
in this case revealed frame shift mutation in codon 
1309 (c.3927_3931delAAAGA p.Q1309fs). The muta-
tion leads to premature termination of the APC gene 
protein product [5, 7]. This deletion is the most fre-
quent mutation in the Polish FAP patients [28]. In Eu-
rope its frequency is 8–20%, in Singapore it is 36% 
of all of APC gene mutations, but it has not been de-
tected in Spain and Portugal [7, 15]. The obtained data 
show irregular distribution of this mutation in different 
populations. Although some authors found intra- and 
inter-family variation of phenotypes in patients with 
the same APC gene mutation, but in most cases muta-
tion in codon 1309 leads to early onset of the disease 
accompanied by hundreds of polyps at a young age, 
early occurrence of colorectal cancer and ECM [15]. 
In proband FAP was combined with congenital anoma-
lies of growth and development of teeth with high arch 
palate as the typical features of Gardner’s syndrome. 
Proband’s father, who died at the age of 43 years, was 
previously diagnosed with polyposis of the stomach 
and colon, had congenital malformations of the facial 
skeleton also. Proband’s sister at the age of 13 years 
was referred to DNA analysis because of the presence 
of ECM: abnormalities in growth and development 
of teeth, high arch palate, arachnodactylia, presence 
of sandal-type gap with fault detection of finger line, 
joint hypermobility, scoliosis of spine of I–II levels. The 
marker mutation of the APC gene was confirmed in the 
sister of proband before the manifestations of intes-
tinal symptoms. Congenital hypertrophy of the retinal 
pigment epithelium, the frequent phenotypic marker 
of Gardner’s syndrome, was not found in the proband 
and her sister. According to the literature data the ECM 
among relatives of patients with FAP would enable 
clinicians to predict affected members and provide 
a useful lead for genetic testing [7, 8].
The pedigree of proband’s family with Gard-
ner’s syndrome is shown in Fig. 1. At the age 
of 22 years proband underwent total colectomy, 
supraanal resection of the rectum with ileoanal 
pouch with the formation of S-shaped anastomosis 
for FAP. Fifteen months after total colectomy in the 
proband it was diagnosed an intestinal obstruction 
caused by tumors with multiple localization in the 
small intestine, ulceration and secondary inflammatory 
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changes. The patient was re-operated on intestinal 
obstruction caused by the overgrowth of tumors. Op-
eration was completed with the formation single lumen 
jejunal tube. Microscopic examination of the tumor 
revealed that it was made up of bundles of elongated 
fusiform, oval and epithelioid cells interspersed with 
fibrous la yers and located in hyalinized stroma. Some 
clusters formed palisade-shaped structures. Tumor 
cells had eosinophilic cytoplasm and centrally located 
fusiform nuclei contained fine-grained chromatin. 
Some of them were hyperchromic nuclei. Low mitotic 
activity was revealed. Necrosis was not observed. The 
obtained results confirmed the detection of GIST in the 
small intestine (Fig. 2). Immunohistochemical studies 
revealed that tumor cells express vimentin (Fig. 3) and 
CD117 (Fig. 4).
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Fig. 1. The pedigree of proband’s family with Gardner’s syndrome
Fig. 2. GIST sample from the small intestine. Hematoxylin and 
eosin (H & E), × 40
Fig. 3. GIST sample from the small intestine. Cytoplasmic ex-
pression of vimentin by tumour cells, × 400
Fig. 4. GIST sample from the small intestine. Marked cytoplas-
mic expression of CD117 by tumour cells, × 400
Immunohistochemical study also determined 
that tumor cells do not express desmin and CD34. 
The negative reaction with antibody to desmin allowed 
us to exclude the presence of tumor that has arisen 
in muscle tissue.
In this report we describe a case of GIST in 24-year-
old woman in 15 months after total colectomy due 
to the FAP. Two similar cases of GIST in the small intes-
tine in FAP are described in the literature: a 30-year-old 
man who presented with severe debilitation, anemia 
and diarrhea over two months [24] and the 29-year-
old woman with metachronous GIST 15 months after 
proctocolectomy indicating the possible occurrence 
of these neoplasms after surgery [25]. About 80–90% 
GIST are known to be caused by KIT proto-oncogene 
mutations or mutations in proto-oncogene of platelet-
derived growth factor receptor alpha polypeptide 
(PDGFRA), receptor tyrosine kinase (RTK). More than 
100 different mutations have been described, each be-
ing associated with specific clinical and/or histological 
property of tumors. Prognosis depends on the spec-
trum of mutations. In particular, patients with a muta-
tion in the 11th exon of KIT gene respond to treatment 
better and have a favourable prognosis [29, 30]. 
Although the role of KIT or PDGFRA mutations in the 
pathogenesis of GIST is certain, their value in the origin 
of GIST, which developed in FAP is not very clear, due 
to low incidence of disease. We have described the 
case of GIST in the woman with Gardner’s syndrome, 
the mutation of APC gene carrier. It indicates possible 
importance of such mutation in the occurrence of this 
neoplasm. We suggest that is necessary the dynamic 
monitoring of the proband’s sister, the carrier of mar-
ker APC gene mutation, for identify the prognostic 
dangerous type of neoplasia, including GIST. The study 
of stromal tumors is given much emphasis in current 
literature, as understanding of their pathogenesis will 
enable us to develop effective targeted therapy.
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